Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EFPIA objects to ‘pressure’ from EMA over theoretical medicines shortages

This article was originally published in Scrip

Executive Summary

EFPIA, the federation of R&D-based industry associations, is using concern about the impact of forthcoming legislation on drug shortages to call for the European Medicines Agency to look more closely the impact of low prices. EFPIA is warning the agency that it must find a pragmatic way to implement the highly problematic Falsified Medicines Directive.

You may also be interested in...



The Netherlands Swaps Germany For Norway To Set Prices

The Netherlands will secure lower medicine prices by referencing Norway instead of Germany to set maximum prices. 

Luxembourg To Establish New Medicines Agency

Luxembourg’s new regulator will work to attract investment and improve public health as well as tackle the growing problem of drug shortages.

Brazilian Regulator Sets New Drug Registration Records

Better dialogue with companies, together with new regulations and ways of working, have helped Brazil’s medicines regulator set new records for registering pharmaceuticals.

Topics

UsernamePublicRestriction

Register

SC019627

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel